{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:07:39Z","timestamp":1771362459984,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000860","name":"European Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005227","name":"Centers for Medicare and Medicaid Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","award":["K12 HS023000-01"],"award-info":[{"award-number":["K12 HS023000-01"]}],"id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013500","name":"Canadian Cardiovascular Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.amjcard.2019.01.034","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T17:00:27Z","timestamp":1548435627000},"page":"1193-1201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-5165","authenticated-orcid":false,"given":"Abhinav","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Lena","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliya","family":"Lokhnygina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihar R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Blazing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.01.034_bib0001","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/CIRCULATIONAHA.109.852749","article-title":"Cardiovascular risk prediction in patients with stable and unstable coronary heart disease","volume":"121","author":"Morrow","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.115.019861","article-title":"Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0003","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jacc.2016.11.070","article-title":"Atherothrombotic risk stratification and ezetimibe for secondary prevention","volume":"69","author":"Bohula","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0004","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0005","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0006","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1067\/mem.2002.122705","article-title":"A neural computational aid to the diagnosis of acute myocardial infarction","volume":"39","author":"Baxt","year":"2002","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(96)91555-X","article-title":"Prospective validation of artificial neural network trained to identify acute myocardial infarction","volume":"347","author":"Baxt","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0008","first-page":"1940","article-title":"Machine learning for risk prediction of acute coronary syndrome","volume":"2014","author":"VanHouten","year":"2014","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms5708","article-title":"A metabolic view on menopause and ageing","volume":"5","author":"Auro","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nmeth.3440","article-title":"Pathway and network analysis of cancer genomes","volume":"12","author":"Creixell","year":"2015","journal-title":"Nat Meth"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0011","first-page":"592","article-title":"Patient clustering with uncoded text in electronic medical records","volume":"2013","author":"Henao","year":"2013","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0012","unstructured":"Henao R., Lucas J.E.. Efficient hierarchical clustering for continuous data. arXiv:1204.4708 [stat.ML]. 2012."},{"key":"10.1016\/j.amjcard.2019.01.034_bib0013","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2014.07.979","article-title":"Clinical implications of chronic heart failure phenotypes defined by cluster analysis","volume":"64","author":"Ahmad","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0014","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","article-title":"Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study","volume":"64","author":"Lindman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0016","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1001\/jama.2016.4839","article-title":"Moving from clinical trials to precision medicine: the role for predictive modeling","volume":"315","author":"Pencina","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0017","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2011.1219","article-title":"The promise of electronic records: around the corner or down the road?","volume":"306","author":"Jha","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ahj.2014.05.004","article-title":"Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population","volume":"168","author":"Blazing","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0019","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ahj.2010.01.003","article-title":"Differences in mortality in acute coronary syndrome symptom clusters","volume":"159","author":"Riegel","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0021","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.NNR.0000263968.01254.d6","article-title":"Symptom clusters in acute myocardial infarction: a secondary data analysis","volume":"56","author":"Ryan","year":"2007","journal-title":"Nurs Res"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pmedr.2017.01.010","article-title":"Race and place differences in patients hospitalized with an acute coronary syndrome: is there double jeopardy? Findings from TRACE-CORE","volume":"6","author":"Goldberg","year":"2017","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0023","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/clc.22570","article-title":"Race and sex differences in management and outcomes of patients after ST-elevation and non-ST-elevation myocardial infarct: results from the NCDR","volume":"39","author":"Edmund Anstey","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003892","article-title":"International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: insights from the NAVIGATOR trial","volume":"6","author":"Harumi Higuchi Dos Santos","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2012.06.006","article-title":"Implications of geographical variation on clinical outcomes of cardiovascular trials","volume":"164","author":"Mentz","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCOUTCOMES.111.962332","article-title":"Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial","volume":"5","author":"Roe","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0027","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjcard.2016.12.021","article-title":"Comparison of delay times from symptom onset to medical contact in blacks versus whites with acute myocardial infarction","volume":"119","author":"Miller","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0028","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2016.07.010","article-title":"The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: a report from the American Heart Association Mission: lifeline program","volume":"180","author":"Kontos","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","article-title":"Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI","volume":"124","author":"McManus","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003670","article-title":"Use and customization of risk scores for predicting cardiovascular events using electronic health record data","volume":"6","author":"Wolfson","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.01.034_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006019","article-title":"Implementing cardiovascular risk prediction in clinical practice: the future is now","volume":"6","author":"Karmali","year":"2017","journal-title":"J Am Heart Assoc"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919301262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919301262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:04:35Z","timestamp":1762077875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919301262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0002914919301262"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.01.034","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}